5/20/2022
Together, the
Lee/Oesterreich laboratory studies the molecular basis of breast cancer development and resistance to therapy with the goal of improving precision medicine and outcomes for breast cancer patients.
Lee also serves as the director of the
Institute of Precision Medicine, a joint effort by UPMC and Pitt. He has published over 160 peer-reviewed research articles. His laboratory is supported by funding from the Department of Defense, Susan G. Komen for the Cure, Breast Cancer Research Foundation and other sources. He serves on numerous national peer-review committees and is on the editorial board of several journals. In 2018, Lee received the Terri L. Chapman Award from Susan G. Komen, the PNC Elsie Hillman Distinguished Scholar Award and the University of Pittsburgh Biomedical Graduate Scholar Association (BGSA) Distinguished Mentor Award.
Oesterreich has also authored over 160 scientific articles in breast cancer, and her research has continuously been funded by Susan G. Komen, Breast Cancer Research Foundation, the National Cancer Institute and other sources. Together with Lee, Oesterreich received the PNC Elsie Hillman Distinguished Scholar Award.
Lee and Oesterreich will join an advisory group of nearly 50 accomplished leaders in breast cancer research and advocacy, representing more than 20 major health institutions across the U.S. The Komen Scholars are the foremost experts in laboratory research, clinical practice, public health and patient advocacy.
Left Photo:
PHOTO DETAILS: (click images for high-res versions)
CREDIT: UPMC
CAPTION: Adrian V. Lee, Ph.D.
Right Photo:
PHOTO DETAILS: (click images for high-res versions)
CREDIT: UPMC
CAPTION: Steffi Oesterreich, Ph.D.